Cellegy, ProStrakan Group Ltd. deal

CLGY granted ProStrakan exclusive European rights to Cellegesic ( Rectogesic) 0.4% topical nitroglycerin ointment

Read the full 144 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE